Dipyridamole Induced Ischemia and Biomarkers

Completed

• Conditions: Ischemic Heart Disease; Ischemic Attack

• Registration Number: NCT03688815
• Lead Sponsor: University of Pecs

Brief Summary

Analysis of certain biomarkers and transient myocardial perfusion deficit revealed by myocardial perfusion scintigraphy.

Detailed Description

The prospectively enrolled patients were followed up to 5 years. Adverse major events (MI, stroke, death) suffered during follow-up were retrospectively analysed.

Study Timeline

• Study Start: 2009-01-01
• Primary Completion: 2010-01-01
• Study Completion: 2017-01-01
• Status Verified: 2018-09
• Study First Submitted: 2018-09-25
• Study First Submitted QC: 2018-09-27
• Last Update Submitted: 2018-09-27
• Study First Posted: 2018-09-28
• Last Update Posted: 2018-09-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. written informed consent. 2. clinical diagnosis of ischemic heart disease (IHD) -

Exclusion Criteria

1. refused written informed consent. 2. lost data during follow-up

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Myocardial perfusion abnormality	5 year follow-up after MPS	Myocardial perfusion was quantified based on myocardial perfusion scintigraphy (MPS).

Trial Locations

Locations (1)

University of Pecs; 🇭🇺 Pécs, Baranya, Hungary